Breaking News

Today
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
On The Fly
Fly Intel: Wall Street's top stories at midday » 12:48
08/05/20
08/05
12:48
08/05/20
12:48
DIS

Disney

$128.20 /

+10.75 (+9.15%)

, NVAX

Novavax

$174.54 /

+17.39 (+11.07%)

, JNJ

Johnson & Johnson

$147.96 /

+0.76 (+0.52%)

, PFE

Pfizer

$38.33 /

-0.05 (-0.13%)

, MRNA

Moderna

$75.60 /

-2.88 (-3.67%)

, LVGO

Livongo Health

$135.39 /

-9.09 (-6.29%)

, CVS

CVS Health

$64.21 /

-0.78 (-1.20%)

, FLGT

Fulgent Genetics

$36.85 /

+7.17 (+24.16%)

, ENLC

EnLink Midstream

$3.11 /

+0.57 (+22.49%)

, LPSN

LivePerson

$56.54 /

+10.29 (+22.25%)

, AIZ

Assurant

$122.92 /

+15.84 (+14.79%)

, EVER

EverQuote

$45.02 /

-9.235 (-17.02%)

, VAPO

Vapotherm

$32.62 /

-20.84 (-38.98%)

, NEWR

New Relic

$55.10 /

-18.405 (-25.04%)

, CDLX

Cardlytics

$65.67 /

-7.01 (-9.65%)

, BNTX

BioNTech

$81.21 /

-1.96 (-2.36%)

, TDOC

Teladoc

$214.70 /

-34.41 (-13.81%)

The S&P is heading…

Open Full Text

ShowHide Related Items >><<
DIS Disney
$128.20 /

+10.75 (+9.15%)

NVAX Novavax
$174.54 /

+17.39 (+11.07%)

JNJ Johnson & Johnson
$147.96 /

+0.76 (+0.52%)

PFE Pfizer
$38.33 /

-0.05 (-0.13%)

MRNA Moderna
$75.60 /

-2.88 (-3.67%)

LVGO Livongo Health
$135.39 /

-9.09 (-6.29%)

CVS CVS Health
$64.21 /

-0.78 (-1.20%)

FLGT Fulgent Genetics
$36.85 /

+7.17 (+24.16%)

ENLC EnLink Midstream
$3.11 /

+0.57 (+22.49%)

LPSN LivePerson
$56.54 /

+10.29 (+22.25%)

AIZ Assurant
$122.92 /

+15.84 (+14.79%)

EVER EverQuote
$45.02 /

-9.235 (-17.02%)

VAPO Vapotherm
$32.62 /

-20.84 (-38.98%)

NEWR New Relic
$55.10 /

-18.405 (-25.04%)

CDLX Cardlytics
$65.67 /

-7.01 (-9.65%)

BNTX BioNTech
$81.21 /

-1.96 (-2.36%)

TDOC Teladoc
$214.70 /

-34.41 (-13.81%)

DIS Disney
$128.20 /

+10.75 (+9.15%)

10:16 Today
Fly Intel: Top five analyst upgrades
08:17 Today JPMorgan
Disney remains top pick in media post Q3 results at JPMorgan
08:07 Today Needham
Needham says still 'too early' to buy Disney, keeps Hold rating after earnings
07:49 Today BMO Capital
Disney price target raised to $150 from $140 at BMO Capital
NVAX Novavax
$174.54 /

+17.39 (+11.07%)

10:16 Today
Fly Intel: Top five analyst downgrades
10:16 Today
Fly Intel: Top five analyst upgrades
09:19 Today B. Riley FBR
Novavax price target raised to $257 from $184 at B. Riley FBR
06:58 Today Cantor Fitzgerald
Novavax price target raised to $211 from $148 at Cantor Fitzgerald
JNJ Johnson & Johnson
$147.96 /

+0.76 (+0.52%)

07/30/20 BofA
BofA says hard to compare Moderna COVID data to competing preclinical data
07/29/20 Laidlaw
Curis initiated with a Buy at Laidlaw
07/17/20 Goldman Sachs
J&J valuation discount to S&P 500 'too wide,' says Goldman Sachs
07/17/20 Citi
Johnson & Johnson price target raised to $170 from $165 at Citi
PFE Pfizer
$38.33 /

-0.05 (-0.13%)

08/03/20 Jefferies
Moderna's Phase 3 data on COVID vaccine could come by October, says Jefferies
07/30/20 BofA
BofA says hard to compare Moderna COVID data to competing preclinical data
07/30/20 Morgan Stanley
Pfizer price target raised to $42 from $36 at Morgan Stanley
07/30/20 Mizuho
Pfizer price target raised to $43 from $38 at Mizuho
MRNA Moderna
$75.60 /

-2.88 (-3.67%)

10:50 Today Piper Sandler
Piper reiterates $134 target on Moderna, notes Q2 ended with $3.1B cash
08/03/20 Jefferies
Moderna's Phase 3 data on COVID vaccine could come by October, says Jefferies
07/30/20 BofA
BofA says hard to compare Moderna COVID data to competing preclinical data
07/27/20 Piper Sandler
Piper reiterates $134 Moderna target on start of Phase III vaccine trial
LVGO Livongo Health
$135.39 /

-9.09 (-6.29%)

10:46 Today JPMorgan
JPMorgan views combination with Livongo as positive for Teladoc
09:35 Today Piper Sandler
Teladoc 'thinking bigger' with Livongo Health takeover deal, says Piper Sandler
07/29/20 RBC Capital
Livongo Health ending re-seller relationship with CVS Health, says RBC Capital
07/15/20
Fly Intel: Top five analyst initiations
CVS CVS Health
$64.21 /

-0.78 (-1.20%)

07/29/20 RBC Capital
Livongo Health ending re-seller relationship with CVS Health, says RBC Capital
07/01/20 SVB Leerink
CVS Health reinstated with a Market Perform at SVB Leerink
06/01/20 Stephens
Molina Healthcare price target raised to $215 from $202 at Stephens
05/14/20
Fly Intel: Top five analyst upgrades
FLGT Fulgent Genetics
$36.85 /

+7.17 (+24.16%)

09:42 Today Piper Sandler
Fulgent Genetics price target raised to $68 from $31 at Piper Sandler
07/27/20 Piper Sandler
Fulgent Genetics price target raised to $31 from $21 at Piper Sandler
06/17/20 Piper Sandler
Fulgent Genetics price target raised to $21 from $18 at Piper Sandler
05/29/20 BTIG
Fulgent Genetics initiated with a Buy at BTIG
ENLC EnLink Midstream
$3.11 /

+0.57 (+22.49%)

05/06/20 Mizuho
EnLink Midstream price target lowered to $2.50 from $7 at Mizuho
04/02/20 Credit Suisse
EnLink Midstream downgraded to Underperform from Neutral at Credit Suisse
03/24/20 Barclays
EnLink Midstream downgraded to Underweight from Equal Weight at Barclays
03/12/20 Raymond James
EnLink Midstream downgraded to Market Perform from Outperform at Raymond James
LPSN LivePerson
$56.54 /

+10.29 (+22.25%)

09:18 Today B. Riley FBR
LivePerson price target raised to $63 from $49 at B. Riley FBR
09:14 Today Barclays
LivePerson price target raised to $64 from $49 at Barclays
09:08 Today Craig-Hallum
LivePerson price target raised to $60 from $34 at Craig-Hallum
08:01 Today Roth Capital
LivePerson price target raised to $75 from $53 at Roth Capital
AIZ Assurant
$122.92 /

+15.84 (+14.79%)

10/03/19 SunTrust
Assurant price target raised to $145 from $140 at SunTrust
EVER EverQuote
$45.02 /

-9.235 (-17.02%)

07/14/20 BofA
EverQuote downgraded to Underperform from Neutral at BofA
07/14/20 BofA
EverQuote downgraded to Underperform from Neutral at BofA
06/02/20 Oppenheimer
EverQuote price target raised to $65 from $50 at Oppenheimer
05/27/20 Canaccord
EverQuote price target raised to $60 from $50 at Canaccord
VAPO Vapotherm
$32.62 /

-20.84 (-38.98%)

07/13/20 BTIG
Vapotherm price target raised to $53 from $32 at BTIG
06/05/20 Canaccord
Vapotherm price target raised to $34 from $30 at Canaccord
05/06/20 Canaccord
Vapotherm price target raised to $30 from $20 at Canaccord
04/14/20 Canaccord
Vapotherm price target raised to $20 from $14 at Canaccord
NEWR New Relic
$55.10 /

-18.405 (-25.04%)

08:38 Today UBS
New Relic sales turnaround taking longer than expected, says UBS
08:25 Today JPMorgan
New Relic downgraded to Neutral on strategy change at JPMorgan
04:47 Today JPMorgan
New Relic downgraded to Neutral from Overweight at JPMorgan
08/04/20 BMO Capital
New Relic price target raised to $78 from $70 at BMO Capital
CDLX Cardlytics
$65.67 /

-7.01 (-9.65%)

09:18 Today Craig-Hallum
Cardlytics price target raised to $70 from $50 at Craig-Hallum
07/09/20 SunTrust
Cardlytics price target raised to $75 from $55 at SunTrust
05/12/20 Craig-Hallum
Cardlytics price target lowered to $50 from $70 at Craig-Hallum
05/12/20 SunTrust
Cardlytics price target raised to $55 from $50 at SunTrust
BNTX BioNTech
$81.21 /

-1.96 (-2.36%)

08/03/20 Jefferies
Moderna's Phase 3 data on COVID vaccine could come by October, says Jefferies
07/30/20 BofA
BofA says hard to compare Moderna COVID data to competing preclinical data
07/30/20 Morgan Stanley
Pfizer price target raised to $42 from $36 at Morgan Stanley
07/21/20
Fly Intel: Top five analyst upgrades
TDOC Teladoc
$214.70 /

-34.41 (-13.81%)

10:46 Today JPMorgan
JPMorgan views combination with Livongo as positive for Teladoc
09:35 Today Piper Sandler
Teladoc 'thinking bigger' with Livongo Health takeover deal, says Piper Sandler
07/30/20 Wells Fargo
Teladoc price target raised to $175 from $135 at Wells Fargo
07/30/20 Canaccord
Teladoc price target raised to $255 from $195 at Canaccord
DIS Disney
$128.20 /

+10.75 (+9.15%)

NVAX Novavax
$174.54 /

+17.39 (+11.07%)

JNJ Johnson & Johnson
$147.96 /

+0.76 (+0.52%)

PFE Pfizer
$38.33 /

-0.05 (-0.13%)

MRNA Moderna
$75.60 /

-2.88 (-3.67%)

LVGO Livongo Health
$135.39 /

-9.09 (-6.29%)

CVS CVS Health
$64.21 /

-0.78 (-1.20%)

FLGT Fulgent Genetics
$36.85 /

+7.17 (+24.16%)

ENLC EnLink Midstream
$3.11 /

+0.57 (+22.49%)

LPSN LivePerson
$56.54 /

+10.29 (+22.25%)

AIZ Assurant
$122.92 /

+15.84 (+14.79%)

EVER EverQuote
$45.02 /

-9.235 (-17.02%)

VAPO Vapotherm
$32.62 /

-20.84 (-38.98%)

NEWR New Relic
$55.10 /

-18.405 (-25.04%)

CDLX Cardlytics
$65.67 /

-7.01 (-9.65%)

BNTX BioNTech
$81.21 /

-1.96 (-2.36%)

TDOC Teladoc
$214.70 /

-34.41 (-13.81%)

  • 23
    Jul
  • 19
    May
  • 07
    May
  • 12
    Feb
  • 06
    Feb
  • 12
    Dec
  • 14
    Nov
  • 10
    Oct
  • 11
    Sep
DIS Disney
$128.20 /

+10.75 (+9.15%)

NVAX Novavax
$174.54 /

+17.39 (+11.07%)

JNJ Johnson & Johnson
$147.96 /

+0.76 (+0.52%)

PFE Pfizer
$38.33 /

-0.05 (-0.13%)

MRNA Moderna
$75.60 /

-2.88 (-3.67%)

LVGO Livongo Health
$135.39 /

-9.09 (-6.29%)

CVS CVS Health
$64.21 /

-0.78 (-1.20%)

LPSN LivePerson
$56.54 /

+10.29 (+22.25%)

BNTX BioNTech
$81.21 /

-1.96 (-2.36%)

TDOC Teladoc
$214.70 /

-34.41 (-13.81%)

DIS Disney
$128.20 /

+10.75 (+9.15%)

NVAX Novavax
$174.54 /

+17.39 (+11.07%)

JNJ Johnson & Johnson
$147.96 /

+0.76 (+0.52%)

PFE Pfizer
$38.33 /

-0.05 (-0.13%)

MRNA Moderna
$75.60 /

-2.88 (-3.67%)

LVGO Livongo Health
$135.39 /

-9.09 (-6.29%)

CVS CVS Health
$64.21 /

-0.78 (-1.20%)

FLGT Fulgent Genetics
$36.85 /

+7.17 (+24.16%)

ENLC EnLink Midstream
$3.11 /

+0.57 (+22.49%)

LPSN LivePerson
$56.54 /

+10.29 (+22.25%)

AIZ Assurant
$122.92 /

+15.84 (+14.79%)

VAPO Vapotherm
$32.62 /

-20.84 (-38.98%)

NEWR New Relic
$55.10 /

-18.405 (-25.04%)

CDLX Cardlytics
$65.67 /

-7.01 (-9.65%)

BNTX BioNTech
$81.21 /

-1.96 (-2.36%)

TDOC Teladoc
$214.70 /

-34.41 (-13.81%)

DIS Disney
$128.20 /

+10.75 (+9.15%)

NVAX Novavax
$174.54 /

+17.39 (+11.07%)

JNJ Johnson & Johnson
$147.96 /

+0.76 (+0.52%)

PFE Pfizer
$38.33 /

-0.05 (-0.13%)

MRNA Moderna
$75.60 /

-2.88 (-3.67%)

LVGO Livongo Health
$135.39 /

-9.09 (-6.29%)

CVS CVS Health
$64.21 /

-0.78 (-1.20%)

LPSN LivePerson
$56.54 /

+10.29 (+22.25%)

AIZ Assurant
$122.92 /

+15.84 (+14.79%)

VAPO Vapotherm
$32.62 /

-20.84 (-38.98%)

CDLX Cardlytics
$65.67 /

-7.01 (-9.65%)

BNTX BioNTech
$81.21 /

-1.96 (-2.36%)

TDOC Teladoc
$214.70 /

-34.41 (-13.81%)

On The Fly
Street Fight: JPMorgan says buy Novavax, Ladenburg says sell after vaccine data » 11:08
08/05/20
08/05
11:08
08/05/20
11:08
NVAX

Novavax

$170.87 /

+13.72 (+8.73%)

, MRNA

Moderna

$74.31 /

-4.17 (-5.31%)

, JNJ

Johnson & Johnson

$148.12 /

+0.92 (+0.63%)

, PFE

Pfizer

$38.24 /

-0.14 (-0.36%)

, BNTX

BioNTech

$80.00 /

-3.17 (-3.81%)

Shares of Novavax (NVAX)…

Open Full Text

ShowHide Related Items >><<
NVAX Novavax
$170.87 /

+13.72 (+8.73%)

MRNA Moderna
$74.31 /

-4.17 (-5.31%)

JNJ Johnson & Johnson
$148.12 /

+0.92 (+0.63%)

PFE Pfizer
$38.24 /

-0.14 (-0.36%)

BNTX BioNTech
$80.00 /

-3.17 (-3.81%)

NVAX Novavax
$170.87 /

+13.72 (+8.73%)

10:16 Today
Fly Intel: Top five analyst downgrades
10:16 Today
Fly Intel: Top five analyst upgrades
09:19 Today B. Riley FBR
Novavax price target raised to $257 from $184 at B. Riley FBR
06:58 Today Cantor Fitzgerald
Novavax price target raised to $211 from $148 at Cantor Fitzgerald
MRNA Moderna
$74.31 /

-4.17 (-5.31%)

10:50 Today Piper Sandler
Piper reiterates $134 target on Moderna, notes Q2 ended with $3.1B cash
08/03/20 Jefferies
Moderna's Phase 3 data on COVID vaccine could come by October, says Jefferies
07/30/20 BofA
BofA says hard to compare Moderna COVID data to competing preclinical data
07/27/20 Piper Sandler
Piper reiterates $134 Moderna target on start of Phase III vaccine trial
JNJ Johnson & Johnson
$148.12 /

+0.92 (+0.63%)

07/30/20 BofA
BofA says hard to compare Moderna COVID data to competing preclinical data
07/29/20 Laidlaw
Curis initiated with a Buy at Laidlaw
07/17/20 Goldman Sachs
J&J valuation discount to S&P 500 'too wide,' says Goldman Sachs
07/17/20 Citi
Johnson & Johnson price target raised to $170 from $165 at Citi
PFE Pfizer
$38.24 /

-0.14 (-0.36%)

08/03/20 Jefferies
Moderna's Phase 3 data on COVID vaccine could come by October, says Jefferies
07/30/20 BofA
BofA says hard to compare Moderna COVID data to competing preclinical data
07/30/20 Morgan Stanley
Pfizer price target raised to $42 from $36 at Morgan Stanley
07/30/20 Mizuho
Pfizer price target raised to $43 from $38 at Mizuho
BNTX BioNTech
$80.00 /

-3.17 (-3.81%)

08/03/20 Jefferies
Moderna's Phase 3 data on COVID vaccine could come by October, says Jefferies
07/30/20 BofA
BofA says hard to compare Moderna COVID data to competing preclinical data
07/30/20 Morgan Stanley
Pfizer price target raised to $42 from $36 at Morgan Stanley
07/21/20
Fly Intel: Top five analyst upgrades
NVAX Novavax
$170.87 /

+13.72 (+8.73%)

MRNA Moderna
$74.31 /

-4.17 (-5.31%)

JNJ Johnson & Johnson
$148.12 /

+0.92 (+0.63%)

PFE Pfizer
$38.24 /

-0.14 (-0.36%)

BNTX BioNTech
$80.00 /

-3.17 (-3.81%)

  • 23
    Jul
  • 19
    May
  • 12
    Feb
  • 06
    Feb
  • 10
    Oct
NVAX Novavax
$170.87 /

+13.72 (+8.73%)

MRNA Moderna
$74.31 /

-4.17 (-5.31%)

JNJ Johnson & Johnson
$148.12 /

+0.92 (+0.63%)

PFE Pfizer
$38.24 /

-0.14 (-0.36%)

BNTX BioNTech
$80.00 /

-3.17 (-3.81%)

NVAX Novavax
$170.87 /

+13.72 (+8.73%)

MRNA Moderna
$74.31 /

-4.17 (-5.31%)

JNJ Johnson & Johnson
$148.12 /

+0.92 (+0.63%)

PFE Pfizer
$38.24 /

-0.14 (-0.36%)

BNTX BioNTech
$80.00 /

-3.17 (-3.81%)

NVAX Novavax
$170.87 /

+13.72 (+8.73%)

MRNA Moderna
$74.31 /

-4.17 (-5.31%)

JNJ Johnson & Johnson
$148.12 /

+0.92 (+0.63%)

PFE Pfizer
$38.24 /

-0.14 (-0.36%)

BNTX BioNTech
$80.00 /

-3.17 (-3.81%)

Periodicals
Canada in agreement with Pfizer, Moderna for COVID vaccines, BNN Bloomberg says » 10:18
08/05/20
08/05
10:18
08/05/20
10:18
MRNA

Moderna

$74.15 /

-4.33 (-5.52%)

, PFE

Pfizer

$38.29 /

-0.09 (-0.23%)

BNN Bloomberg reported…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PFE Pfizer
$38.29 /

-0.09 (-0.23%)

MRNA Moderna
$74.15 /

-4.33 (-5.52%)

MRNA Moderna
$74.15 /

-4.33 (-5.52%)

08/03/20 Jefferies
Moderna's Phase 3 data on COVID vaccine could come by October, says Jefferies
07/30/20 BofA
BofA says hard to compare Moderna COVID data to competing preclinical data
07/27/20 Piper Sandler
Piper reiterates $134 Moderna target on start of Phase III vaccine trial
07/27/20 BMO Capital
Moderna price target lowered to $94 from $112 at BMO Capital
PFE Pfizer
$38.29 /

-0.09 (-0.23%)

07/30/20 Morgan Stanley
Pfizer price target raised to $42 from $36 at Morgan Stanley
07/30/20 Mizuho
Pfizer price target raised to $43 from $38 at Mizuho
PFE Pfizer
$38.29 /

-0.09 (-0.23%)

MRNA Moderna
$74.15 /

-4.33 (-5.52%)

  • 19
    May
  • 12
    Feb
PFE Pfizer
$38.29 /

-0.09 (-0.23%)

MRNA Moderna
$74.15 /

-4.33 (-5.52%)

PFE Pfizer
$38.29 /

-0.09 (-0.23%)

MRNA Moderna
$74.15 /

-4.33 (-5.52%)

PFE Pfizer
$38.29 /

-0.09 (-0.23%)

MRNA Moderna
$74.15 /

-4.33 (-5.52%)

Downgrade
Fly Intel: Top five analyst downgrades » 10:16
08/05/20
08/05
10:16
08/05/20
10:16
AAPL

Apple

$440.01 /

+1.21 (+0.28%)

, NVAX

Novavax

$185.03 /

+27.88 (+17.74%)

, TSN

Tyson Foods

$64.55 /

-0.58 (-0.89%)

, EMN

Eastman Chemical

$71.88 /

+0.83 (+1.17%)

, WLTW

Willis Towers Watson

$203.80 /

-0.45 (-0.22%)

Catch up on today's…

Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Apple (AAPL) downgraded to Neutral from Buy at BofA with analyst Wamsi Mohan saying shares have experienced a rapid multiple expansion since June although 2021 estimates have largely been unchanged in that time. 2. Novavax (NVAX) downgraded to Sell from Neutral at Ladenburg with analyst Michael Higgins saying the vaccine induced "robust" immune responses against the spike protein that exceeded convalescent sera levels from patients infected with or recovering from COVID-19 infection; however, Novavax is one of the last companies in "Operation Warp Speed" to present its initial data and its current valuation overestimates the revenue and net profit opportunity. 3. Tyson Foods (TSN) downgraded to Neutral from Outperform at Credit Suisse with analyst Robert Moskow saygin he expects "another weak year ahead" for the two most important divisions of the company, Chicken and Prepared Foods, due to oversupplied conditions in the chicken industry and weak demand in the foodservice channel. 4. Eastman Chemical (EMN) downgraded to Neutral from Buy at BofA with analyst Matthew DeYoe citing valuation. 5. Willis Towers downgraded to Market Perform from Outperform at Raymond James with analyst Gregory Peters saying the company in Q2 reported 60 basis point of adjusted operating margin contraction compared with increases at peers Aon plc (AON) and Marsh & McLennan (MMC). This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

ShowHide Related Items >><<
WLTW Willis Towers Watson
$203.80 /

-0.45 (-0.22%)

TSN Tyson Foods
$64.55 /

-0.58 (-0.89%)

NVAX Novavax
$185.03 /

+27.88 (+17.74%)

EMN Eastman Chemical
$71.88 /

+0.83 (+1.17%)

AAPL Apple
$440.01 /

+1.21 (+0.28%)

AAPL Apple
$440.01 /

+1.21 (+0.28%)

08:17 Today Wells Fargo
Apple price target raised to $485 from $450 at Wells Fargo
07:19 Today Bernstein
2021 could be 'big year' for Apple iPhones, says Bernstein
06:19 Today BofA
BofA downgrades Apple to Neutral, ups price target to $470
06:09 Today BofA
Apple downgraded to Neutral from Buy at BofA
NVAX Novavax
$185.03 /

+27.88 (+17.74%)

10:16 Today
Fly Intel: Top five analyst upgrades
09:19 Today B. Riley FBR
Novavax price target raised to $257 from $184 at B. Riley FBR
06:58 Today Cantor Fitzgerald
Novavax price target raised to $211 from $148 at Cantor Fitzgerald
06:42 Today JPMorgan
JPMorgan upgrades Novavax on potential 'best-in-class' COVID vaccine
TSN Tyson Foods
$64.55 /

-0.58 (-0.89%)

06:00 Today Credit Suisse
Tyson Foods downgraded to Neutral from Outperform at Credit Suisse
07/28/20 Seaport Global
Tyson Foods initiated with a Neutral at Seaport Global
06/10/20 Credit Suisse
Tyson Foods price target raised to $75 from $70 at Credit Suisse
06/04/20
Fly Intel: Top five analyst upgrades
EMN Eastman Chemical
$71.88 /

+0.83 (+1.17%)

09:28 Today Scotiabank
Scotiabank downgraded Eastman Chemical on valuation after outperformance
08:05 Today Deutsche Bank
Eastman Chemical price target raised to $80 from $70 at Deutsche Bank
06:17 Today BofA
Eastman Chemical downgraded to Neutral from Buy at BofA
06:15 Today BofA
Eastman Chemical downgraded to Neutral from Buy at BofA
WLTW Willis Towers Watson
$203.80 /

-0.45 (-0.22%)

07:33 Today Raymond James
Raymond James downgrades Willis Towers Watson with focus on merger
07:30 Today Raymond James
Aon plc downgraded to Underperform from Market Perform at Raymond James
05:44 Today Raymond James
Willis Towers downgraded to Market Perform from Outperform at Raymond James
06/25/20 Jefferies
Aon plc price target raised to $225 from $214 at Jefferies
WLTW Willis Towers Watson
$203.80 /

-0.45 (-0.22%)

TSN Tyson Foods
$64.55 /

-0.58 (-0.89%)

NVAX Novavax
$185.03 /

+27.88 (+17.74%)

EMN Eastman Chemical
$71.88 /

+0.83 (+1.17%)

AAPL Apple
$440.01 /

+1.21 (+0.28%)

TSN Tyson Foods
$64.55 /

-0.58 (-0.89%)

NVAX Novavax
$185.03 /

+27.88 (+17.74%)

AAPL Apple
$440.01 /

+1.21 (+0.28%)

WLTW Willis Towers Watson
$203.80 /

-0.45 (-0.22%)

TSN Tyson Foods
$64.55 /

-0.58 (-0.89%)

NVAX Novavax
$185.03 /

+27.88 (+17.74%)

AAPL Apple
$440.01 /

+1.21 (+0.28%)

TSN Tyson Foods
$64.55 /

-0.58 (-0.89%)

NVAX Novavax
$185.03 /

+27.88 (+17.74%)

EMN Eastman Chemical
$71.88 /

+0.83 (+1.17%)

AAPL Apple
$440.01 /

+1.21 (+0.28%)

AAPL Apple
$440.01 /

+1.21 (+0.28%)

On The Fly
Apple downgrade, Disney upgrade among today's top calls on Wall Street » 10:05
08/05/20
08/05
10:05
08/05/20
10:05
AAPL

Apple

$439.78 /

+0.98 (+0.22%)

, DIS

Disney

$129.70 /

+12.25 (+10.43%)

, NVAX

Novavax

$181.67 /

+24.52 (+15.60%)

, TSN

Tyson Foods

$63.93 /

-1.2 (-1.84%)

, SAFM

Sanderson Farms

$110.45 /

-4.225 (-3.68%)

, PANW

Palo Alto Networks

$258.64 /

+3.875 (+1.52%)

Check out today's top…

Open Full Text

ShowHide Related Items >><<
TSN Tyson Foods
$63.93 /

-1.2 (-1.84%)

SAFM Sanderson Farms
$110.45 /

-4.225 (-3.68%)

PANW Palo Alto Networks
$258.64 /

+3.875 (+1.52%)

NVAX Novavax
$181.67 /

+24.52 (+15.60%)

DIS Disney
$129.70 /

+12.25 (+10.43%)

AAPL Apple
$439.78 /

+0.98 (+0.22%)

AAPL Apple
$439.78 /

+0.98 (+0.22%)

08:17 Today Wells Fargo
Apple price target raised to $485 from $450 at Wells Fargo
07:19 Today Bernstein
2021 could be 'big year' for Apple iPhones, says Bernstein
06:19 Today BofA
BofA downgrades Apple to Neutral, ups price target to $470
06:09 Today BofA
Apple downgraded to Neutral from Buy at BofA
DIS Disney
$129.70 /

+12.25 (+10.43%)

08:17 Today JPMorgan
Disney remains top pick in media post Q3 results at JPMorgan
08:07 Today Needham
Needham says still 'too early' to buy Disney, keeps Hold rating after earnings
07:49 Today BMO Capital
Disney price target raised to $150 from $140 at BMO Capital
06:36 Today Guggenheim
Disney upgraded to Buy from Neutral at Guggenheim
NVAX Novavax
$181.67 /

+24.52 (+15.60%)

09:19 Today B. Riley FBR
Novavax price target raised to $257 from $184 at B. Riley FBR
06:58 Today Cantor Fitzgerald
Novavax price target raised to $211 from $148 at Cantor Fitzgerald
06:42 Today JPMorgan
JPMorgan upgrades Novavax on potential 'best-in-class' COVID vaccine
06:38 Today Ladenburg
Ladenburg downgrades Novavax to Sell with $105 target after vaccine data
TSN Tyson Foods
$63.93 /

-1.2 (-1.84%)

06:00 Today Credit Suisse
Tyson Foods downgraded to Neutral from Outperform at Credit Suisse
07/28/20 Seaport Global
Tyson Foods initiated with a Neutral at Seaport Global
06/10/20 Credit Suisse
Tyson Foods price target raised to $75 from $70 at Credit Suisse
06/04/20
Fly Intel: Top five analyst upgrades
SAFM Sanderson Farms
$110.45 /

-4.225 (-3.68%)

05:59 Today Credit Suisse
Sanderson Farms downgraded to Neutral from Outperform at Credit Suisse
06/04/20 BofA
BofA cuts Pilgrim's Pride, Sanderson Farms targets after price fixing indictment
06/03/20 Stephens
Stephens downgrades Pilgrim's Pride after indictment, suspends targets on peers
05/11/20 Stephens
Sanderson Farms price target raised to $150 from $110 at Stephens
PANW Palo Alto Networks
$258.64 /

+3.875 (+1.52%)

08/04/20 BTIG
Palo Alto Networks upgraded to Buy from Neutral at BTIG
07/28/20 Jefferies
Palo Alto Networks price target raised to $300 from $275 at Jefferies
07/09/20 Citi
Citi recommends overweight Palo Alto Networks, underweight Fortinet pair trade
06/04/20 Cleveland Research
Palo Alto momentum extending into Q4, says Cleveland Research
TSN Tyson Foods
$63.93 /

-1.2 (-1.84%)

SAFM Sanderson Farms
$110.45 /

-4.225 (-3.68%)

PANW Palo Alto Networks
$258.64 /

+3.875 (+1.52%)

NVAX Novavax
$181.67 /

+24.52 (+15.60%)

DIS Disney
$129.70 /

+12.25 (+10.43%)

AAPL Apple
$439.78 /

+0.98 (+0.22%)

TSN Tyson Foods
$63.93 /

-1.2 (-1.84%)

SAFM Sanderson Farms
$110.45 /

-4.225 (-3.68%)

PANW Palo Alto Networks
$258.64 /

+3.875 (+1.52%)

NVAX Novavax
$181.67 /

+24.52 (+15.60%)

DIS Disney
$129.70 /

+12.25 (+10.43%)

AAPL Apple
$439.78 /

+0.98 (+0.22%)

TSN Tyson Foods
$63.93 /

-1.2 (-1.84%)

SAFM Sanderson Farms
$110.45 /

-4.225 (-3.68%)

PANW Palo Alto Networks
$258.64 /

+3.875 (+1.52%)

NVAX Novavax
$181.67 /

+24.52 (+15.60%)

DIS Disney
$129.70 /

+12.25 (+10.43%)

AAPL Apple
$439.78 /

+0.98 (+0.22%)

TSN Tyson Foods
$63.93 /

-1.2 (-1.84%)

PANW Palo Alto Networks
$258.64 /

+3.875 (+1.52%)

NVAX Novavax
$181.67 /

+24.52 (+15.60%)

DIS Disney
$129.70 /

+12.25 (+10.43%)

AAPL Apple
$439.78 /

+0.98 (+0.22%)

AAPL Apple
$439.78 /

+0.98 (+0.22%)

Periodicals
TSMC, Foxconn among those interested in stake in SoftBank-owned Arm, Nikkei says » 09:59
08/05/20
08/05
09:59
08/05/20
09:59
TSM

TSMC

$82.23 /

+2.05 (+2.56%)

, AAPL

Apple

$438.25 /

-0.55 (-0.13%)

, SFTBY

SoftBank

$0.00 /

+ (+0.00%)

Apple (AAPL) suppliers,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TSM TSMC
$82.23 /

+2.05 (+2.56%)

SFTBY SoftBank
$0.00 /

+ (+0.00%)

AAPL Apple
$438.25 /

-0.55 (-0.13%)

TSM TSMC
$82.23 /

+2.05 (+2.56%)

07/29/20 Bernstein
ASML downgraded to Market Perform on customer slowdown at Bernstein
07/27/20 Lynx
Might be prudent to take profits on TSMC, wait for pullback, Lynx says
07/27/20 Credit Suisse
TSMC upgraded to Outperform from Neutral at Credit Suisse
07/24/20 Raymond James
Intel 7nm delay positive for AMD, TSMC, Nvidia, says Raymond James
AAPL Apple
$438.25 /

-0.55 (-0.13%)

08:17 Today Wells Fargo
Apple price target raised to $485 from $450 at Wells Fargo
07:19 Today Bernstein
2021 could be 'big year' for Apple iPhones, says Bernstein
06:19 Today BofA
BofA downgrades Apple to Neutral, ups price target to $470
06:09 Today BofA
Apple downgraded to Neutral from Buy at BofA
SFTBY SoftBank
$0.00 /

+ (+0.00%)

07/10/20 Nomura Instinet
SoftBank price target raised to 7,240 yen from 6,640 yen at Nomura Instinet
05/26/20 Citi
SoftBank price target lowered to 7,100 yen from 8,200 yen at Citi
03/24/20 Jefferies
SoftBank upgraded to Buy from Hold at Jefferies
02/13/20 HSBC
SoftBank price target raised to 7,000 yen after Sprint deal approval
TSM TSMC
$82.23 /

+2.05 (+2.56%)

AAPL Apple
$438.25 /

-0.55 (-0.13%)

TSM TSMC
$82.23 /

+2.05 (+2.56%)

SFTBY SoftBank
$0.00 /

+ (+0.00%)

AAPL Apple
$438.25 /

-0.55 (-0.13%)

TSM TSMC
$82.23 /

+2.05 (+2.56%)

SFTBY SoftBank
$0.00 /

+ (+0.00%)

AAPL Apple
$438.25 /

-0.55 (-0.13%)

TSM TSMC
$82.23 /

+2.05 (+2.56%)

AAPL Apple
$438.25 /

-0.55 (-0.13%)

AAPL Apple
$438.25 /

-0.55 (-0.13%)

Conference/Events
FedEx participates in a conference call with Credit Suisse » 09:25
08/05/20
08/05
09:25
08/05/20
09:25
FDX

FedEx

$170.67 /

+1.42 (+0.84%)

Conference call to be…

Conference call to be held on August 5 at 10 am hosted by Credit Suisse.

ShowHide Related Items >><<
FDX FedEx
$170.67 /

+1.42 (+0.84%)

FDX FedEx
$170.67 /

+1.42 (+0.84%)

07/06/20 Argus
FedEx upgraded to Buy from Hold earlier at Argus
07/02/20 Deutsche Bank
FedEx price target raised to $150 from $128 at Deutsche Bank
07/01/20
Fly Intel: Top five analyst upgrades
07/01/20 Cowen
FedEx price target raised to $167 from $156 at Cowen
FDX FedEx
$170.67 /

+1.42 (+0.84%)

FDX FedEx
$170.67 /

+1.42 (+0.84%)

FDX FedEx
$170.67 /

+1.42 (+0.84%)

FDX FedEx
$170.67 /

+1.42 (+0.84%)

Options
Notable open interest changes for August 5th » 08:55
08/05/20
08/05
08:55
08/05/20
08:55
AMD

AMD

$85.04 /

+7.39 (+9.52%)

, ATVI

Activision Blizzard

$86.34 /

+1.575 (+1.86%)

, AAPL

Apple

$438.80 /

+3.14 (+0.72%)

, MSFT

Microsoft

$213.32 /

-3.28 (-1.51%)

Tuesday's total…

Tuesday's total option volume of 26.2 million contracts resulted in net open interest growth of 3.55 million calls and 3.13 million puts. Advanced Micro (AMD), Activision Blizzard (ATVI), Apple (AAPL) and Microsoft (MSFT) saw the greatest growth. Top five new positions opened include 25k CenturyLink (CTL) 8/7 weekly 9.5 puts, 21k Citi (C) Sep-20 50 calls, 20k Occidental Petroleum (OXY) Nov-20 22.5 (nonstd OXY2) calls, 19k Citi (C) Sep-20 50 puts and 17k Microsoft (MSFT) Sep-20 230 puts.

ShowHide Related Items >><<
MSFT Microsoft
$213.32 /

-3.28 (-1.51%)

ATVI Activision Blizzard
$86.34 /

+1.575 (+1.86%)

AMD AMD
$85.04 /

+7.39 (+9.52%)

AAPL Apple
$438.80 /

+3.14 (+0.72%)

AMD AMD
$85.04 /

+7.39 (+9.52%)

08/04/20 Jefferies
AMD price target raised to $95 from $86 at Jefferies
07/29/20
Fly Intel: Top five analyst downgrades
07/29/20
Fly Intel: Top five analyst upgrades
07/29/20 JPMorgan
AMD price target raised to $62 from $52 at JPMorgan
ATVI Activision Blizzard
$86.34 /

+1.575 (+1.86%)

08:43 Today Morgan Stanley
Activision Blizzard price target raised to $100 from $88 at Morgan Stanley
08:39 Today UBS
Activision Blizzard price target raised to $106 from $84 at UBS
07:42 Today Oppenheimer
Activision Blizzard price target raised to $95 from $75 at Oppenheimer
05:04 Today Baird
Activision Blizzard price target raised to $100 from $82 at Baird
AAPL Apple
$438.80 /

+3.14 (+0.72%)

08:17 Today Wells Fargo
Apple price target raised to $485 from $450 at Wells Fargo
07:19 Today Bernstein
2021 could be 'big year' for Apple iPhones, says Bernstein
06:19 Today BofA
BofA downgrades Apple to Neutral, ups price target to $470
06:09 Today BofA
Apple downgraded to Neutral from Buy at BofA
MSFT Microsoft
$213.32 /

-3.28 (-1.51%)

07:03 Today Morgan Stanley
Morgan Stanley says TikTok US operations could be 'compelling' fit for Microsoft
08/04/20 Wedbush
Wedbush sees 75%-80% chance of Microsoft buying TikTok's U.S. operations
08/04/20 Oppenheimer
TikTok presents 'unique opportunity' for Microsoft, says Oppenheimer
08/03/20 Wedbush
Wedbush sees a TikTok deal as big bet from Microsoft on social media space
MSFT Microsoft
$213.32 /

-3.28 (-1.51%)

ATVI Activision Blizzard
$86.34 /

+1.575 (+1.86%)

AMD AMD
$85.04 /

+7.39 (+9.52%)

AAPL Apple
$438.80 /

+3.14 (+0.72%)

MSFT Microsoft
$213.32 /

-3.28 (-1.51%)

ATVI Activision Blizzard
$86.34 /

+1.575 (+1.86%)

AMD AMD
$85.04 /

+7.39 (+9.52%)

AAPL Apple
$438.80 /

+3.14 (+0.72%)

ATVI Activision Blizzard
$86.34 /

+1.575 (+1.86%)

AMD AMD
$85.04 /

+7.39 (+9.52%)

AAPL Apple
$438.80 /

+3.14 (+0.72%)

MSFT Microsoft
$213.32 /

-3.28 (-1.51%)

ATVI Activision Blizzard
$86.34 /

+1.575 (+1.86%)

AMD AMD
$85.04 /

+7.39 (+9.52%)

AAPL Apple
$438.80 /

+3.14 (+0.72%)

AAPL Apple
$438.80 /

+3.14 (+0.72%)

Recommendations
Apple price target raised to $485 from $450 at Wells Fargo » 08:17
08/05/20
08/05
08:17
08/05/20
08:17
AAPL

Apple

$438.80 /

+3.14 (+0.72%)

Wells Fargo analyst Aaron…

Wells Fargo analyst Aaron Rakers raised the firm's price target on Apple to $485 from $450 and keeps an Overweight rating on the shares. The analyst recently completed a worldwide iPhone subscriber base survey. While Rakers fully appreciates this is a very small end user snapshot relative to an active installed base approaching a billion users, he thinks the results point to upside for the upcoming iPhone 12 cycle. His survey found that 84% of iPhone owners are interested in upgrading their smartphones this cycle, despite the impact of coronavirus. His scenario analysis upgrade model based on the survey's results leaves him to consider about 250M-plus iPhones sold, well above his current 2021 217M unit estimate.

ShowHide Related Items >><<
AAPL Apple
$438.80 /

+3.14 (+0.72%)

AAPL Apple
$438.80 /

+3.14 (+0.72%)

07:19 Today Bernstein
2021 could be 'big year' for Apple iPhones, says Bernstein
06:19 Today BofA
BofA downgrades Apple to Neutral, ups price target to $470
06:09 Today BofA
Apple downgraded to Neutral from Buy at BofA
08/04/20 Susquehanna
Cirrus Logic price target raised to $86 from $78 at Susquehanna
AAPL Apple
$438.80 /

+3.14 (+0.72%)

AAPL Apple
$438.80 /

+3.14 (+0.72%)

AAPL Apple
$438.80 /

+3.14 (+0.72%)

AAPL Apple
$438.80 /

+3.14 (+0.72%)

AAPL Apple
$438.80 /

+3.14 (+0.72%)

Hot Stocks
Pfizer, BioNTech to supply Canada with BNT162 mRNA-based vaccine candidate » 08:04
08/05/20
08/05
08:04
08/05/20
08:04
PFE

Pfizer

$38.38 /

+0.025 (+0.07%)

, BNTX

BioNTech

$83.17 /

-2.23 (-2.61%)

Pfizer Canada (PFE) and…

Pfizer Canada (PFE) and BioNTech SE (BNTX) announced an agreement with the Government of Canada to supply their BNT162 mRNA-based vaccine candidate against SARS-CoV-2, subject to clinical success and Health Canada approval. Financial details of the agreement were not disclosed, but the terms were based on the timing of delivery and the volume of doses. As requested by the Government of Canada, deliveries of the vaccine candidate are planned for over the course of 2021. The BNT162 program is based on BioNTech's proprietary mRNA technology and supported by Pfizer's global vaccine development and manufacturing capabilities. The vaccine development program is evaluating at least four experimental vaccine candidates, each of which represents a unique combination of messenger RNA format and target antigen. The BNT162 vaccine candidates are undergoing clinical studies and are not currently approved for distribution anywhere in the world. Both collaborators are committed to developing these novel vaccines with pre-clinical and clinical data at the forefront of all their decision-making. Recently, two of the companies' four investigational vaccine candidates - BNT162b1 and BNT162b2 - received Fast Track designation from the U.S. Food and Drug Administration. This designation was granted based on preliminary data from Phase 1/2 studies that are currently ongoing in the United States and Germany as well as animal immunogenicity studies. On July 27, Pfizer and BioNTech announced that following extensive review of preclinical and clinical data from Phase 1/2 clinical trials, and in consultation with the U.S. FDA's Center for Biologics Evaluation and Research and other global regulators, the companies selected the BNT162b2 vaccine candidate to move forward into a Phase 2/3 study. BNT162b2 encodes an optimized SARS-CoV-2 full length spike glycoprotein, which is the target of virus neutralizing antibodies. In the late-stage trial, the companies will study a 30 microgram dose level in a 2-dose-regimen among up to 30,000 participants aged 18 to 85 years. It is expected to include approximately 120 sites globally including in regions with significant expected SARS-CoV-2 transmission. BNT162b2 has received Fast Track designation from the U.S. FDA. Assuming clinical success, Pfizer and BioNTech are on track to seek regulatory review for BNT162b2 as early as October 2020 and, if regulatory authorization or approval is obtained, plan to supply up to 100 million doses worldwide by the end of 2020 and approximately 1.3 billion doses by the end of 2021. In addition to engagements with governments, Pfizer and BioNTech have provided an expression of interest for possible supply to the COVAX Facility, a mechanism established by Gavi, the Vaccine Alliance, the Coalition for Epidemic Preparedness Innovations and World Health Organization that aims to provide governments, including those in the emerging markets, with early access to a large portfolio of COVID-19 candidate vaccines using a range of technology platforms, produced by multiple manufacturers across the world.

ShowHide Related Items >><<
PFE Pfizer
$38.38 /

+0.025 (+0.07%)

BNTX BioNTech
$83.17 /

-2.23 (-2.61%)

PFE Pfizer
$38.38 /

+0.025 (+0.07%)

08/03/20 Jefferies
Moderna's Phase 3 data on COVID vaccine could come by October, says Jefferies
07/30/20 BofA
BofA says hard to compare Moderna COVID data to competing preclinical data
07/30/20 Morgan Stanley
Pfizer price target raised to $42 from $36 at Morgan Stanley
07/30/20 Mizuho
Pfizer price target raised to $43 from $38 at Mizuho
BNTX BioNTech
$83.17 /

-2.23 (-2.61%)

07/21/20
Fly Intel: Top five analyst upgrades
PFE Pfizer
$38.38 /

+0.025 (+0.07%)

BNTX BioNTech
$83.17 /

-2.23 (-2.61%)

  • 23
    Jul
  • 06
    Feb
  • 10
    Oct
PFE Pfizer
$38.38 /

+0.025 (+0.07%)

BNTX BioNTech
$83.17 /

-2.23 (-2.61%)

PFE Pfizer
$38.38 /

+0.025 (+0.07%)

BNTX BioNTech
$83.17 /

-2.23 (-2.61%)

PFE Pfizer
$38.38 /

+0.025 (+0.07%)

BNTX BioNTech
$83.17 /

-2.23 (-2.61%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.